Federated Hermes’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-70,276
| Closed | -$1.3M | – | 2258 |
|
|
2023
Q3 | $1.3M | Sell |
70,276
-101,474
| -59% | -$1.15M | ﹤0.01% | 1031 |
|
|
2023
Q2 | $1.9M | Buy |
171,750
+69,004
| +67% | +$961K | ﹤0.01% | 970 |
|
|
2023
Q1 | $1.38M | Buy |
102,746
+101,619
| +9,017% | +$1.76M | ﹤0.01% | 1068 |
|
|
2022
Q4 | $13.9K | Buy |
1,127
+1,057
| +1,510% | +$15K | ﹤0.01% | 1835 |
|
|
2022
Q3 | $1K | Buy |
+70
| New | +$1.13K | ﹤0.01% | 2109 |
|
|
2022
Q1 | – | Sell |
-56,198
| Closed | -$915K | – | 2363 |
|
|
2021
Q4 | $915K | Buy |
+56,198
| New | +$947K | ﹤0.01% | 1315 |
|
|
2020
Q2 | – | Sell |
-1
| Closed | -$1K | – | 2407 |
|
|
2020
Q1 | $1K | Sell |
1
-96,983
| -100% | -$8.72M | ﹤0.01% | 2178 |
|
|
2019
Q4 | $12M | Buy |
+96,984
| New | +$8.68M | 0.03% | 556 |
|
|
2019
Q3 | – | Sell |
-977
| Closed | -$78K | – | 2310 |
|
|
2019
Q2 | $78K | Sell |
977
-139,588
| -99% | -$12.5M | ﹤0.01% | 1634 |
|
|
2019
Q1 | $15.7M | Buy |
140,565
+118,264
| +530% | +$12.9M | 0.04% | 413 |
|
|
2018
Q4 | $2.25M | Sell |
22,301
-62,724
| -74% | -$6.5M | 0.01% | 983 |
|
|
2018
Q3 | $10.7M | Buy |
85,025
+78,260
| +1,157% | +$8.28M | 0.03% | 551 |
|
|
2018
Q2 | $568K | Buy |
6,765
+1,025
| +18% | +$75K | ﹤0.01% | 1395 |
|
|
2018
Q1 | $353K | Buy |
5,740
+5,008
| +684% | +$302K | ﹤0.01% | 1446 |
|
|
2017
Q4 | $43K | Sell |
732
-17
| -2% | -$1.07K | ﹤0.01% | 1683 |
|
|
2017
Q3 | $43K | Buy |
749
+138
| +23% | +$14.9K | ﹤0.01% | 1668 |
|
|
2017
Q2 | $74K | Sell |
611
-2,959
| -83% | -$343K | ﹤0.01% | 1616 |
|
|
2017
Q1 | $404K | Buy |
3,570
+914
| +34% | +$107K | ﹤0.01% | 1379 |
|
|
2016
Q4 | $289K | Sell |
2,656
-466
| -15% | -$55.5K | ﹤0.01% | 1442 |
|
|
2016
Q3 | $514K | Buy |
+3,122
| New | +$492K | ﹤0.01% | 1271 |
|
|
2014
Q1 | – | Sell |
-100,200
| Closed | -$6.84M | – | 1799 |
|
|
2013
Q4 | $6.84M | Hold |
100,200
| – | – | 0.02% | 547 |
|
|
2013
Q3 | $6.92M | Buy |
100,200
+200
| +0.2% | +$9.87K | 0.03% | 482 |
|
|
2013
Q2 | $4.48M | Buy |
+100,000
| New | +$3.42M | 0.02% | 610 |
|
Federated Hermes's ICPT Position: Q4 2023 in Review
Federated Hermes sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 70,276 shares — an estimated $1.3M sold.
Federated Hermes first reported a position in ICPT in Q2 2013 and held it in 23 quarters. The position peaked at $15.7M in Q1 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Federated Hermes reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Federated Hermes sold 70,276 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.3M.
- Federated Hermes first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 23 quarters.
- Federated Hermes's Intercept Pharmaceuticals, Inc. position peaked at $15.7M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.